<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國(guó)服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁(yè) > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47028039Nedaplatin 95734-82-0

    Nedaplatin 95734-82-0

    簡(jiǎn)要描述:Nedaplatin 95734-82-0
    Nedaplatin (NSC 375101D) is a derivative of cisplatin and DNA damage agent.

    • 產(chǎn)品型號(hào):abs47028039
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時(shí)間:2026-01-14
    • 訪  問  量:721

    詳細(xì)介紹

    品牌absinCAS95734-82-0
    分子式C2H8N2O3Pt純度>98%
    分子量303.18貨號(hào)abs47028039
    規(guī)格5mg供貨周期現(xiàn)貨
    主要用途is a derivative of cisplatin應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    Nedaplatin 95734-82-0

    產(chǎn)品描述
    描述
    Nedaplatin (NSC 375101D) is a derivative of cisplatin and DNA damage agent.
    純度
    >98%
    儲(chǔ)存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    別名
    奈da鉑;順糖an鉑;NSC 375101D
    外觀
    稻黃色粉末
    可溶性/溶解性
    Water : 15 mg/mL (49.5 mM)
    生物活性
    靶點(diǎn)
    DNA synthesis
    In vitro(體外研究)
    Nedaplatin (Aqupla) is a derivative of cisplatin for inhibition of tumor colony forming units with IC50 of 28.5 μg/mL. Nedaplatin is a platinum compound which is used for cancer chemotherapy. Nedaplatin inhibits the proliferation of SBC-3 cells by 98%, 93%, 75%, 54%, 27%, 6%, and 2% at a concentration of 0.005 μg/mL, 0.01 μg/mL, 0.025 μg/mL, 0.05 μg/mL, 0.1 μg/mL, 0.25 μg/mL, and 0.5 μg/mL, respectively. The IC50 value of Nedaplatin for growth inhibition of SBC-3 cells is 0.053 μg/mL.
    In vivo(體內(nèi)研究)
    The sequential administration of 5-FU prior to nedaplatin or CDDP (FN or FC therapy) results in synergistically enhanced inhibition of tumour growth and prolonged survival in comparison with nedaplatin, CDDP or 5-FU monotherapy. Combined dosing of Nedaplatin with gemcitabine results in synergistically enhanced inhibition of tumor growth in the Ma44 tumor model. Nedaplatin plus Gemcitabine is also effective against Ma44 cells when given late in the therapy, a model for advanced disease. Potent augmentation of growth inhibition by Nedaplatin with Gemcitabine is also found with the NCI-H460 tumor model.
    研究領(lǐng)域
    研究領(lǐng)域
    CancerCancer Metabolism
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    Nedaplatin 95734-82-0溫馨提示:本產(chǎn)品僅作科研實(shí)驗(yàn)使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補(bǔ)充說(shuō)明:

    • 驗(yàn)證碼:

      請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號(hào)申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號(hào)了解更多信息:
    歡迎您關(guān)注我們的微信公眾號(hào)
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    亚洲一级视频在线观看 | 国产综合丁香五月 | 日韩videos | 日本黄色软件视频 | 欧美 日韩 激情 |